Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00BMI
|
|||
Former ID |
DNC009401
|
|||
Drug Name |
N-1,3,4-thiadiazol-2-ylsulfamide
|
|||
Synonyms |
CHEMBL449527; N-1,3,4-thiadiazol-2-ylsulfamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C2H4N4O2S2
|
|||
Canonical SMILES |
C1=NN=C(S1)NS(=O)(=O)N
|
|||
InChI |
1S/C2H4N4O2S2/c3-10(7,8)6-2-5-4-1-9-2/h1H,(H,5,6)(H2,3,7,8)
|
|||
InChIKey |
TXIIDPYBTNXTDC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase I (CA-I) | Target Info | Inhibitor | [1] |
Carbonic anhydrase II (CA-II) | Target Info | Inhibitor | [1] | |
Carbonic anhydrase IV (CA-IV) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Nitrogen metabolism | |||
Proximal tubule bicarbonate reclamation | ||||
Collecting duct acid secretion | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Pathwhiz Pathway | Gastric Acid Production | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes ... Bioorg Med Chem Lett. 2008 Dec 15;18(24):6332-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.